
Commentary|Podcasts|December 2, 2025
Breaking Down CELEBRATE and POLY-HF: Two Paths to Better Cardiac Care
Fact checked by: Ron Panarotti
Advertisement
In this solo episode, Craig Beavers breaks down new data from the CELEBRATE STEMI (NCT04825743) trial and the POLY-HF (NCT04633005) polypill study. He highlights what these findings could mean for real-world practice, from early antiplatelet strategies to improving adherence and outcomes in heart failure.
Show Notes:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Advancing Treatment After CDK4/6 Inhibitor Progression in HR+/HER2– Breast Cancer
2
Pharmacists, Don’t Fear AI: ASHP Framework Shows How to Embrace AI
3
A Supplemental Blood Test to Bridge Gaps in Breast Cancer Screening Access
4
How IV Robotics Are Transforming Sterile Compounding, Supply Chain Control, and Workforce Efficiency
5




















































































































































































































